Paul Offit, MD, director, Vaccine Training Middle, and professor of pediatrics, Youngsters’s Hospital of Philadelphia; professor of vaccinology, Perelman College of Medication, College of Pennsylvania.
CDC: “Vaccines: The Fundamentals,” “When Vaccine is Restricted, Who Will get Vaccinated First?” “Understanding How COVID-19 Vaccines Work,” “Assembly of the Advisory Committee on Immunization Practices (ACIP) November 23,” “Understanding mRNA COVID-19 Vaccines.”
JAMA: “COVID-19 and mRNA Vaccines — First Massive Take a look at for a New Method.”
The Lancet: “Oxford-AstraZeneca COVID-19 vaccine efficacy.”
Fb interview: Mark Zuckerberg and Anthony Fauci, MD, Nov. 30, 2020.
FDA: “Vaccines and Associated Organic Merchandise Advisory Committee Assembly, Dec. 17, 2020.”
Naor Bar-Zeev, PhD, affiliate professor of worldwide well being and vaccinology and deputy director, Worldwide Vaccine Entry Middle, Johns Hopkins Bloomberg College of Public Well being, Baltimore.
Statista.com: “The Price Per Jab of Covid-19 Vaccine Candidates.”
AstraZeneca: “COVID-19 vaccine AZD1222 is healthier tolerated in older adults than youthful adults with related immune responses throughout all age teams.”
The Lancet: “Security and immunogenicity of ChAdOx1nCoV-19 in a prime-boost routine in younger and previous adults (COV002) in a single-blind, randomized, managed, section 2/3 trial.”
Moderna: “Moderna’s COVID-19 Vaccine Candidate Meets its Main Efficacy Endpoint within the First Interim Evaluation of the Section 3 COVE Research.”
BMJ.com: “Covid-19: Moderna vaccine is almost 95% efficient, trial involving excessive threat and aged individuals exhibits.”
CBS Information: “UK warns in opposition to giving Pfizer vaccine to individuals susceptible to extreme allergic reactions.”